5-173235021-T-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004387.4(NKX2-5):c.63A>G(p.Glu21Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 1,611,664 control chromosomes in the GnomAD database, including 104,414 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004387.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NKX2-5 | NM_004387.4 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | ENST00000329198.5 | NP_004378.1 | |
NKX2-5 | NM_001166176.2 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | NP_001159648.1 | ||
NKX2-5 | NM_001166175.2 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | NP_001159647.1 | ||
NKX2-5 | XM_017009071.3 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | XP_016864560.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NKX2-5 | ENST00000329198.5 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | 1 | NM_004387.4 | ENSP00000327758.4 | ||
NKX2-5 | ENST00000424406.2 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | 1 | ENSP00000395378.2 | |||
NKX2-5 | ENST00000521848.1 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | 2 | ENSP00000427906.1 | |||
NKX2-5 | ENST00000517440.1 | c.63A>G | p.Glu21Glu | synonymous_variant | Exon 1 of 2 | 4 | ENSP00000429905.1 |
Frequencies
GnomAD3 genomes AF: 0.440 AC: 66810AN: 151956Hom.: 16539 Cov.: 33
GnomAD3 exomes AF: 0.408 AC: 98893AN: 242538Hom.: 22418 AF XY: 0.394 AC XY: 52382AN XY: 132864
GnomAD4 exome AF: 0.332 AC: 484973AN: 1459590Hom.: 87838 Cov.: 43 AF XY: 0.332 AC XY: 241173AN XY: 726098
GnomAD4 genome AF: 0.440 AC: 66901AN: 152074Hom.: 16576 Cov.: 33 AF XY: 0.446 AC XY: 33180AN XY: 74358
ClinVar
Submissions by phenotype
not specified Benign:10
- -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
p.Glu21Glu in exon 1 of NKX2-5: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 67% (6119/9090) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs2277923). -
- -
- -
- -
- -
- -
- -
Atrial septal defect 7 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at